Fibroid patients build case with
successful pregnancies
Complication rates appear no higher than population averages
as evidence grows for fertility preservation
By: Jane Lowers
Successful pregnancies following uterine
fibroid embolization are debunking the theory that the
procedure should not be recommended for women who want to
conceive despite having heavy fibroid volume. Among a cohort
of more than 1200 embolization patients at an English
hospital, 43 of 98 women who tried to conceive have been
able to do so.
Researchers at Royal Surrey County Hospital in Guildford,
U.K., have tracked pregnancy incidence and outcomes in their large fibroid
embolization population. The 43 women have had 53 pregnancies to date, with the
following results:
29 successful births;
four ongoing pregnancies;
four terminations;
13 miscarriages; and
one ectopic pregnancy.
Those figures bolster an earlier and smaller report from the
Ontario UFE Trial, which logged 24 pregnancies in 21 women among 555 treated in
Canada in a report published in the January 2005 issue of Obstetrics &
Gynecology. Those post-UFE pregnancies led to 18 live births, including nine
cesarean deliveries, according to lead research Gaylene Pron, Ph.D., an
epidemiologist at the University of Toronto. Four women miscarried, and two
elected to have their pregnancies terminated.
Considering that women who undergo fibroid treatment tend to
be older than the average child-bearing population, data on miscarriages and
pregnancy complications are consistent with the general obstetrics literature,
said lead investigator Dr. Woodruff Walker. The women in the Surrey cohort who
had successful births averaged 35.8 years of age, while those who miscarried
were significantly older at an average of 41.8 years. The miscarriage rate of
24.5% is within normal range for that age.
Women who had had fibroid embolization were far more likely
than their peers to deliver by cesarean-76% of the cases-probably because their
obstetricians treated their deliveries with extra caution. Intrauterine growth
restriction, one of the chief concerns about fibroid embolization and its effect
on pregnancy, was no more frequent in this population than in the general
literature, Walker said.
The population of successful pregnancies includes several
women who had undergone myomectomy before, concurrent with, or following
embolization.
The average time from fibroid embolization to delivery was 32
months. Among the 43 women, 18 had previously received infertility treatment for
18 months to seven years.
With only a few published articles demonstrating UFE's safety
for women who hope to become pregnant, the ob/gyn community has been hesitant to
embrace it for this population. In a February 2004 statement, the American
College of Obstetricians and Gynecologists wrote that the procedure was
"investigational or relatively contraindicated in women wishing to retain
fertility."
With new data in hand, Walker hopes to change that
reluctance.
"It is scientifically invalid to say that no patient wishing
to become pregnant should have uterine fibroid embolization," Walker said. "It's
not a tenable position."